copper sulfate has been researched along with Bone Marrow Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Dong, C; Gong, R; Jiang, B; Li, G; Lu, Y; Ma, Y; Qiao, Z; Wang, Y; Zhang, L; Zhang, Y; Zheng, Z | 1 |
Mandal, M; Ramachandran, S | 1 |
2 other study(ies) available for copper sulfate and Bone Marrow Diseases
Article | Year |
---|---|
Uvangoletin induces mitochondria-mediated apoptosis in HL-60 cells in vitro and in vivo without adverse reactions of myelosuppression, leucopenia and gastrointestinal tract disturbances.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Diseases; Columbidae; Copper Sulfate; Cyclophosphamide; Drugs, Chinese Herbal; Ethanol; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukopenia; Mice; Mice, Nude; Mitochondria; Nausea; Neoplasm Proteins; Random Allocation; Rats; Stomach Ulcer; Xenograft Model Antitumor Assays | 2016 |
Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Ascites; Azurin; Bone Marrow Diseases; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Copper Sulfate; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Lymphoma, Non-Hodgkin; Male; Mice; Oxidation-Reduction; Pseudomonas aeruginosa; Weight Loss | 2011 |